158 related articles for article (PubMed ID: 31981154)
1. Delayed contrast enhancement of hepatic parenchyma after intravenous sonographic contrast agent: unusual phenomenon. Case report and review of literature.
Tarnoki DL; Tarnoki AD; Sukosd H; Folhoffer A; Harkanyi Z
J Ultrasound; 2021 Mar; 24(1):3-9. PubMed ID: 31981154
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous delayed enhancement of hepatic parenchyma after intravenous infusion of sonographic contrast agent: a new hypothesis.
Caruso G; Martegani A; Aiani L; Borghi C; Verderame F; Campisi A; Salvaggio G; Lagalla R; Cardinale AE
Radiol Med; 2007 Feb; 112(1):56-63. PubMed ID: 17310291
[TBL] [Abstract][Full Text] [Related]
3. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
Seitz K; Strobel D
Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
5. [Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions].
Strunk H; Börner N; Stuckmann G; Fröhlich E; Hadizadeh D
Rofo; 2005 Oct; 177(10):1394-404. PubMed ID: 16170709
[TBL] [Abstract][Full Text] [Related]
6. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
Yanagisawa K; Moriyasu F; Miyahara T; Yuki M; Iijima H
Ultrasound Med Biol; 2007 Feb; 33(2):318-25. PubMed ID: 17207907
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
8. Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30,222 Cases.
Tang C; Fang K; Guo Y; Li R; Fan X; Chen P; Chen Z; Liu Q; Zou Y
J Ultrasound Med; 2017 Mar; 36(3):531-538. PubMed ID: 28072475
[TBL] [Abstract][Full Text] [Related]
9. Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT.
Passamonti M; Vercelli A; Azzaretti A; Rodolico G; Calliada F
Radiol Med; 2005 Apr; 109(4):358-69. PubMed ID: 15883520
[TBL] [Abstract][Full Text] [Related]
10. Characterization of focal liver lesions with contrast-enhanced ultrasound.
Piscaglia F; Lencioni R; Sagrini E; Pina CD; Cioni D; Vidili G; Bolondi L
Ultrasound Med Biol; 2010 Apr; 36(4):531-50. PubMed ID: 20350680
[TBL] [Abstract][Full Text] [Related]
11. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced sonography in the diagnosis of hepatic hemangiomas: atypical appearance due to the washout of microbubbles.
Giannetti A; Franci L; Grechi C; Giangregorio F
J Clin Ultrasound; 2013; 41(6):361-5. PubMed ID: 22610668
[TBL] [Abstract][Full Text] [Related]
13. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
von Herbay A; Vogt C; Willers R; Häussinger D
J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
[TBL] [Abstract][Full Text] [Related]
14. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
[TBL] [Abstract][Full Text] [Related]
15. Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma.
Li C; Wang W; Ding H; Huang B; Cao J; Mao F; Ji Z
J Clin Ultrasound; 2011 Oct; 39(8):447-53. PubMed ID: 21626512
[TBL] [Abstract][Full Text] [Related]
16. Contrast enhanced ultrasound for focal liver lesions: how accurate is it?
Barr RG
Abdom Radiol (NY); 2018 May; 43(5):1128-1133. PubMed ID: 28718042
[TBL] [Abstract][Full Text] [Related]
17. Bolus versus continuous infusion of microbubble contrast agent for liver ultrasound by using an automatic power injector in humans: A pilot study.
Quaia E; Gennari AG; Angileri R; Cova MA
J Clin Ultrasound; 2016; 44(3):136-42. PubMed ID: 26302446
[TBL] [Abstract][Full Text] [Related]
18. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.
Xu HX; Lu MD; Liu GJ; Xie XY; Xu ZF; Zheng YL; Liang JY
J Ultrasound Med; 2006 Jan; 25(1):23-33. PubMed ID: 16371552
[TBL] [Abstract][Full Text] [Related]
19. Prolonged heterogeneous liver enhancement on contrast-enhanced ultrasound.
Cui XW; Ignee A; Hocke M; Seitz K; Schrade G; Dietrich CF
Ultraschall Med; 2014 Jun; 35(3):246-52. PubMed ID: 23888425
[TBL] [Abstract][Full Text] [Related]
20. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
